VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10019029 | HBV | ENSG00000138115.15 | protein_coding | CYP2C8 | No | No | 1558 | B7Z1F5 P10632 |
TVIS10015676 | HBV | ENSG00000138115.15 | protein_coding | CYP2C8 | No | No | 1558 | B7Z1F5 P10632 |
TVIS10026383 | HBV | ENSG00000138115.15 | protein_coding | CYP2C8 | No | No | 1558 | B7Z1F5 P10632 |
TVIS10026384 | HBV | ENSG00000138115.15 | protein_coding | CYP2C8 | No | No | 1558 | B7Z1F5 P10632 |
TVIS10020306 | HBV | ENSG00000138115.15 | protein_coding | CYP2C8 | No | No | 1558 | B7Z1F5 P10632 |
TVIS44006054 | HTLV-1 | ENSG00000138115.15 | protein_coding | CYP2C8 | No | No | 1558 | B7Z1F5 P10632 |
TVIS44010081 | HTLV-1 | ENSG00000138115.15 | protein_coding | CYP2C8 | No | No | 1558 | B7Z1F5 P10632 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | CYP2C8 |
---|---|
DrugBank ID | DB03796 |
Drug Name | Palmitic Acid |
Target ID | BE0002887 |
UniProt ID | P10632 |
Regulation Type | |
PubMed IDs | 14676196 |
Citations | Schoch GA, Yano JK, Wester MR, Griffin KJ, Stout CD, Johnson EF: Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. J Biol Chem. 2004 Mar 5;279(10):9497-503. Epub 2003 Dec 15. |
Groups | Approved |
Direct Classification | Long-chain fatty acids |
SMILES | CCCCCCCCCCCCCCCC(O)=O |
Pathways | Cerivastatin Action Pathway; Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD); Ethylmalonic Encephalopathy; Familial Hypercholanemia (FHCA); Desmosterolosis; Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency); Congenital Bile Acid Synthesis Defect Type III; Glycerolipid Metabolism; Ibandronate Action Pathway; Cerebrotendinous Xanthomatosis (CTX); Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Carnitine Palmitoyl Transferase Deficiency II; Hyper-IgD Syndrome; Zellweger Syndrome; Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD); Steroid Biosynthesis; Hypercholesterolemia; Risedronate Action Pathway; Mevalonic Aciduria; Glutaric Aciduria Type I; Alendronate Action Pathway; CHILD Syndrome; D-Glyceric Acidura; Lovastatin Action Pathway; Wolman Disease; Bile Acid Biosynthesis; Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD); Glycerol Kinase Deficiency; Atorvastatin Action Pathway |
PharmGKB | |
ChEMBL | CHEMBL82293 |